Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | C5 | P01031 | 1/20 | 0.33 |
| ▸ | THRA | P10827 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8340269 | 1.00 | SMPD1 (0.36) | SMPD1SMN1; SMN2GAATDP1L3MBTL1 | |
| SCHEMBL8339656 | 1.00 | SMPD1 (0.36) | SMPD1SMN1; SMN2GAATDP1L3MBTL1 | |
| SCHEMBL8338874 | 0.99 | SMN1; SMN2 (0.36) | SMPD1SMN1; SMN2GAATDP1L3MBTL1 | |
| SCHEMBL8334662 | 0.96 | SMN1; SMN2 (0.37) | SMPD1SMN1; SMN2GAATDP1L3MBTL1 | |
| SCHEMBL8340185 | 0.92 | NPSR1 (0.35) | SMN1; SMN2 | |
| SCHEMBL8334645 | 0.92 | SMPD1 (0.34) | SMPD1SMN1; SMN2GAATDP1L3MBTL1 | |
| SCHEMBL8335988 | 0.92 | SMPD1 (0.34) | SMPD1SMN1; SMN2GAATDP1L3MBTL1 | |
| SCHEMBL8336974 | 0.92 | SMPD1 (0.34) | SMPD1SMN1; SMN2GAATDP1L3MBTL1 | |
| SCHEMBL8340153 | 0.91 | SMN1; SMN2 (0.35) | SMPD1SMN1; SMN2GAATDP1L3MBTL1 | |
| SCHEMBL8338169 | 0.88 | HIF1A (0.34) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5977177-A | Substituted benzenesulfonylureas and-thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-11-02 | — | — | US | disclosed |
| US-5880155-A | TREATMENT OF CARDIOVASCULAR DISORDERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-03-09 | — | — | US | disclosed |